Pharmaceutical Analytical Testing Outsourcing Market Size, Share, Growth Analysis, By Services (Bioanalytical Testing, Method Development & Validation), By End Use (Pharmaceutical Companies, Biopharmaceutical Companies), By Region - Industry Forecast 2025-2032

Pharmaceutical Analytical Testing Outsourcing Market size was valued at USD 8.32 Billion in 2023 and is poised to grow from USD 9.02 Billion in 2024 to USD 17.23 Billion by 2032, growing at a CAGR of 8.42% during the forecast period (2025-2032).

Human health underwent a revolution with the invention of drugs. Only if these medications are delivered in the right dosage and are free of contaminants will they accomplish their intended purpose. medications are estimated using a variety of chemical and technical techniques that were developed periodically to make medications serve their intended purpose. It is, therefore, imperative to detect and quantify the same since these drugs could pose threat in their use. These may, during various stages of production, storage or even distribution, accumulate contaminants. It cannot be done without using analytical instruments and methods. 

Analytical evaluation facilities help in optimizing and controlling various processes, in characterizing biosimilars and biologics, in controlling product quality instantly, and in enhancing productivity. One of the important reasons for outsourcing analytical testing services is the availability of expensive analytical instruments, which are not available in house, and skilled personnel. Another key factor enhancing the demand for analytical testing services is the rising biological development. The goal of the Solidarity Trial is to assess the relative efficiency of four treatment options against COVID-19 as compared with the standard of care intervention. The Solidarity Trial aims to rapidly assess whether any of the drugs reduce the disease progression or improve the chances of survival by enrolling patients in multiple countries.